THALASSEMIA N ME

Subtitle

Reblozyl

REBLOZYL

« Back to Album Photo 1 of 4 Previous | Next
REBLOZYL
FDA approves Reblozyl for treatment of anaemia in beta thalassemia in adults needing regular red blood cell (RBC) transfusions. It's designed to regulate late-stage maturation of red blood cells for reducing the RBC transfusion burden for patients.
Posted by Goh Chun Hui (Jack Goh) on November 26, 2019 Full Size|

Post a Comment

Oops!

Oops, you forgot something.

Oops!

The words you entered did not match the given text. Please try again.

Already a member? Sign In

0 Comments